IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Life Science Advisors, LLC

Q4 2024 Holdings

Filed 2025-02-06 | 13 holdings | $819.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kymera Therapeutics, Inc.(KYMR)Common Stock501575104$197.0M4,896,46224.0%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$188.9M8,019,35423.1%
Disc Medicine, Inc.(IRON)Common Stock254604101$159.1M2,509,45619.4%
Third Harmonic Bio, Inc.(THRD)Common Stock88427A107$107.0M10,402,28613.1%
Day One Biopharmaceuticals, Inc.(DAWN)Common Stock23954D109$81.5M6,430,2579.9%
Korro Bio, Inc.(KRRO)Common Stock500946108$43.3M1,137,1495.3%
Vigil Neuroscience, Inc.(VIGL)Common Stock92673K108$9.9M5,836,8741.2%
Generation Bio, Co.(GBIOGBX)Common Stock37148K100$8.8M8,279,4841.1%
Ikena Oncology, Inc.Common Stock45175G108$8.2M5,018,1781.0%
Q32 Bio, Inc.(QTTB)Common Stock746964105$7.2M2,092,1060.9%
Aerovate Therapeutics, Inc.Common Stock008064107$4.8M1,799,2320.6%
Tectonic Therapeutics, Inc.(TECX)Common Stock878972108$3.6M78,4470.4%
Spero Therapeutics, Inc.(SPRO)Common Stock84833T103$314.4K305,2550.0%